Defence Therapeutics

Overview
News
Biosimilars?
Product stageSegments
Seed
?
Diversified Drug Developers
?

Defence Therapeutics is a Canadian biopharmaceutical company focused on developing innovative immune-oncology vaccines and drug delivery technologies. The company's core technology, the Accum platform, enables precise delivery of vaccine antigens and antibody-drug conjugates (ADCs) to target cells, potentially improving efficacy against cancer and infectious diseases. Defence's lead product, AccuTOX, is a cancer-killing technology that has shown promise in preclinical studies for treating various types of tumors, including lung, breast, colon, melanoma, and lymphoma. In March 2024, Defence was awarded a US patent for AccuTOX, providing market exclusivity until late 2042. The company is also developing AccuTRIC, a novel Radio-Immuno-Conjugate (RIC) that combines AccuTOX with Auger electron emitter elements to treat hard-to-treat cancers. In July 2024, Defence received approval from Health Canada to commence a Phase I clinical trial evaluating AccuTOX as a monotherapy and in combination with Opdualag for patients with unresectable stage IIIB to IV melanoma.

Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
1680 – 200 Burrard Street Vancouver BC CAN
Founded year:
2017
Employees:
11-50
IPO status:
Public
Total funding:
USD 3.4 mn
Last Funding:
USD 1.1 mn (Post IPO Equity; Feb 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.